<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0035-0052</journal-id>
<journal-title><![CDATA[Revista mexicana de pediatría]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. mex. pediatr.]]></abbrev-journal-title>
<issn>0035-0052</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Mexicana de Pediatría A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0035-00522024000300092</article-id>
<article-id pub-id-type="doi">10.35366/119372</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Comparación de las manifestaciones cutáneas de pacientes pediátricos con dermatitis atópica con las de pacientes con inmunodeficiencias primarias]]></article-title>
<article-title xml:lang="en"><![CDATA[Comparison of skin manifestations in pediatric patients with atopic dermatitis with those of patients with primary immunodeficiencies]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Obregón-García]]></surname>
<given-names><![CDATA[Jennifer Alejandra]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Múzquiz-Zermeño]]></surname>
<given-names><![CDATA[David]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Navarrete-Solís]]></surname>
<given-names><![CDATA[Josefina]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Instituto Mexicano del Seguro Social (IMSS) Unidad Médica de Alta Especialidad (UMAE) No. 25 Noreste ]]></institution>
<addr-line><![CDATA[Monterrey Nuevo León]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Instituto Mexicano del Seguro Social (IMSS) Unidad Médica de Alta Especialidad (UMAE) No. 25 Noreste Departamento de Inmunología]]></institution>
<addr-line><![CDATA[Monterrey Nuevo León]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Instituto Mexicano del Seguro Social (IMSS) Unidad Médica de Alta Especialidad (UMAE) No. 25 Noreste Departamento de Dermatología]]></institution>
<addr-line><![CDATA[Monterrey Nuevo León]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2024</year>
</pub-date>
<volume>91</volume>
<numero>3</numero>
<fpage>92</fpage>
<lpage>95</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0035-00522024000300092&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0035-00522024000300092&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0035-00522024000300092&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Introducción:  En pacientes con inmunodeficiencias primarias (IDP) las manifestaciones cutáneas son frecuentes, las cuales pueden ser similares a las de los pacientes con dermatitis atópica (DA).  Objetivo:  Comparar las manifestaciones dermatológicas de pacientes con IDP con las de pacientes con DA.  Material y métodos:  Estudio retrospectivo, observacional y comparativo. Se incluyeron 50 pacientes con DA y 48 con IDP, atendidos en la Unidad Médica de Alta Especialidad No. 25, ubicada en Monterrey, Nuevo León.  Resultados:  La edad promedio fue 7.1 años; hubo predominio de pacientes del sexo masculino (61.2%). En los pacientes con DA, la xerosis (n = 22, 44%) fue la manifestación cutánea más común, seguido del eccema (n = 19, 38%). En contraste, el eccema (n = 37, 77.1%) fue más frecuente en el grupo de IDP. Las complicaciones infecciosas de piel y Anexos se presentaron en ambos grupos de pacientes, pero las de mayor gravedad fueron en pacientes con IDP.  Conclusiones:  Existen diferencias en las manifestaciones cutáneas de los pacientes con DA e IDP, lo cual puede ayudar para mejorar el proceso diagnóstico en pacientes con IDP.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  Introduction:  In patients with primary immunodeficiencies (PID), skin manifestations are common, which may be similar to those in patients with atopic dermatitis (AD).  Objective:  To compare the dermatological manifestations of patients with PID with those of patients with AD.  Material and methods:  Retrospective, observational and comparative study. Fifty patients with AD and 48 with PID treated at the High Specialty Medical Unit No. 25, located in Monterrey, Nuevo León, were included.  Results:  The mean age was 7.1 years; there was a predominance of male patients (61.2%). In patients with AD, xerosis (n = 22, 44%) was the most common skin manifestation, followed by eczema (n = 19, 38%). In contrast, eczema (n = 37, 77.1%) was more frequent in the PID group. Infectious skin complications occurred in both groups of patients, but were more severe in patients with PID.  Conclusions:  There are differences in the skin manifestations of patients with AD and PID, which may help to improve the diagnostic process in patients with PID.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[dermatitis atópica]]></kwd>
<kwd lng="es"><![CDATA[inmunodeficiencia primaria]]></kwd>
<kwd lng="es"><![CDATA[eccema]]></kwd>
<kwd lng="es"><![CDATA[manifestaciones cutáneas]]></kwd>
<kwd lng="en"><![CDATA[atopic dermatitis]]></kwd>
<kwd lng="en"><![CDATA[primary immunodeficiency]]></kwd>
<kwd lng="en"><![CDATA[eczema]]></kwd>
<kwd lng="en"><![CDATA[skin manifestation]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Relan]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Lehman]]></surname>
<given-names><![CDATA[HK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Common dermatologic manifestations of primary immune deficiencies]]></article-title>
<source><![CDATA[Curr Allergy Asthma Rep]]></source>
<year>2014</year>
<volume>14</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>480</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kilic]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
<name>
<surname><![CDATA[Ozel]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Hafizoglu]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Karaca]]></surname>
<given-names><![CDATA[NE]]></given-names>
</name>
<name>
<surname><![CDATA[Aksu]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Kutukculer]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The prevalences [correction] and patient characteristics of primary immunodeficiency diseases in Turkey--two centers study]]></article-title>
<source><![CDATA[J Clin Immunol]]></source>
<year>2013</year>
<volume>33</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>74-83</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tangye]]></surname>
<given-names><![CDATA[SG]]></given-names>
</name>
<name>
<surname><![CDATA[Al-Herz]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Bousfiha]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Chatila]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Cunningham-Rundles]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Etzioni]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee]]></article-title>
<source><![CDATA[J Clin Immunol]]></source>
<year>2020</year>
<volume>40</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>24-64</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Basak]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Abdelhakim]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Cafone]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cutaneous manifestations of primary immunodeficiency]]></article-title>
<source><![CDATA[Ind J Paediatr Derm]]></source>
<year>2017</year>
<volume>18</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>155</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mancini]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Chan]]></surname>
<given-names><![CDATA[LS]]></given-names>
</name>
<name>
<surname><![CDATA[Paller]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Partial albinism with immunodeficiency: Griscelli syndrome: report of a case and review of the literature]]></article-title>
<source><![CDATA[J Am Acad Dermatol]]></source>
<year>1998</year>
<volume>38</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>295-300</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lewis]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[JH]]></given-names>
</name>
<name>
<surname><![CDATA[Boyd]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Duvic]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Feldman]]></surname>
<given-names><![CDATA[SR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cutaneous manifestations of genodermatoses and primary immunodeficiency]]></article-title>
<source><![CDATA[Dermatol Online J]]></source>
<year>2019</year>
<volume>25</volume>
<numero>6</numero>
<issue>6</issue>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Al-Herz]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Nanda]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Skin Manifestations in primary immunodeficient children]]></article-title>
<source><![CDATA[Pediatr Dermatol]]></source>
<year>2011</year>
<volume>28</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>494-501</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Berron-Ruiz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Berron-Perez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Ruiz-Maldonado]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cutaneous markers of primary immunodeficiency diseases in children]]></article-title>
<source><![CDATA[Pediatr Dermatol]]></source>
<year>2000</year>
<volume>17</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>91-6</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Liquidano-Pérez]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Maza-Ramos]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Yamazaki-Nakashimada]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Barragán-Arévalo]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Lugo-Reyes]]></surname>
<given-names><![CDATA[SO]]></given-names>
</name>
<name>
<surname><![CDATA[Scheffler-Mendoza]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Inmunodeficiencia combinada debida a deficiencia de DOCK8. Lo que sabemos hasta ahora]]></article-title>
<source><![CDATA[Rev Alerg Méx]]></source>
<year>2022</year>
<volume>69</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>31-47</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nepesov]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Firtina]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Aygun]]></surname>
<given-names><![CDATA[FD]]></given-names>
</name>
<name>
<surname><![CDATA[Burtenece]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Cokugras]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Camcioglu]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diagnosis of primary immunodeficiency diseases in pediatric patients hospitalized for recurrent, severe, or unusual infections]]></article-title>
<source><![CDATA[Allergol Immunopathol (Madr)]]></source>
<year>2022</year>
<volume>50</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>50-6</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gür-Cetinkaya]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Sahiner]]></surname>
<given-names><![CDATA[ÜM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Childhood atopic dermatitis: current developments, treatment approaches, and future expectations]]></article-title>
<source><![CDATA[Turk J Med Sci]]></source>
<year>2019</year>
<volume>49</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>963-84</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pucci]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Novembre]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Cammarata]]></surname>
<given-names><![CDATA[MG]]></given-names>
</name>
<name>
<surname><![CDATA[Bernardini]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Monaco]]></surname>
<given-names><![CDATA[MG]]></given-names>
</name>
<name>
<surname><![CDATA[Calogero]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Scoring atopic dermatitis in infants and young children: distinctive features of the SCORAD index]]></article-title>
<source><![CDATA[Allergy]]></source>
<year>2005</year>
<volume>60</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>113-6</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Eldeniz]]></surname>
<given-names><![CDATA[FC]]></given-names>
</name>
<name>
<surname><![CDATA[Gul]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Yorulmaz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Guner]]></surname>
<given-names><![CDATA[SN]]></given-names>
</name>
<name>
<surname><![CDATA[Keles]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Reisli]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluation of the 10 warning signs in primary and secondary immunodeficient patients]]></article-title>
<source><![CDATA[Front Immunol]]></source>
<year>2022</year>
<volume>13</volume>
<page-range>900055</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bahrami]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sayyahfar]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Soltani]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Khodadost]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Moazzami]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Rezaei]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluation of the frequency and diagnostic delay of primary immunodeficiency disorders among suspected patients based on the 10 warning sign criteria: a cross-sectional study in Iran]]></article-title>
<source><![CDATA[Allergol Immunopathol (Madr)]]></source>
<year>2020</year>
<volume>48</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>711-9</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
